Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease
Pengwei Hu(Xinjiang Technical Institute of Physics & Chemistry), Antonio J. Vallejo‐Vaz(Instituto de Biomedicina de Sevilla), Jacques Genest(McGill University Health Centre), Christophe Stevens(Public Health England), Mansour Taghavi Azar Sharabiani(Imperial College London), Gerald F. Watts(Royal Perth Hospital), Kanika Dharmayat(Public Health England), Rebecca Jones(Charing Cross Hospital), Kausik K. Ray(Imperial College London)
Cited by 554
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k